Coya Therapeutics operates under the executive leadership of Dr. Arun Swaminathan, who serves as the Chief Executive Officer. Having stepped into the role following a planned leadership transition from founder Dr. Howard Berman, Dr. Swaminathan directs the company's corporate strategy, clinical trials development, and strategic biopharmaceutical partnerships.